<DOC>
	<DOCNO>NCT02062034</DOCNO>
	<brief_summary>The purpose study evaluate efficacy ubiquinone combine antioxidant therapy progression , clinical regression , oxidative stress marker mitochondrial dysfunction non-proliferative diabetic retinopathy .</brief_summary>
	<brief_title>Efficacy Ubiquinone Combined Antioxidant Therapy Non-proliferative Diabetic Retinopathy</brief_title>
	<detailed_description>The investigator interested demonstrate efficacy Ubiquinone combine antioxidant therapy pharmacological management diabetic retinopathy since early stage .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Copper</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>Patients type 2 diabetes mellitus Patients non proliferative diabetic retinopathy Glycated hemoglobin &lt; 12.0 % Signing informed consent Patients clinically significant macular edema Patients diabetic retinopathy advance lesion require require specific treatment ( laser , vitrectomy ) Pretreatment argon laser excimer laser Ophthalmology surgery Any associate ocular pathology ( glaucoma , cataract , change cornea dystrophy , macular degeneration ) Pregnancy , lactation , inadequate use contraception Antioxidant drug and/or supplement six month previous enrollment Renal and/or hepatic failure Age 30 75 year Severe cardiovascular disease ( myocardial infarction , stroke , severe peripheral vasculopathy ) Blood dyscrasia Have cancer serious illness Neurodegenerative process Allergy vitamin</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Oxidative stress</keyword>
	<keyword>Mitochondrial dysfunction</keyword>
	<keyword>Ubiquinone</keyword>
	<keyword>Antioxidant combine therapy</keyword>
	<keyword>Diabetic retinopathy</keyword>
</DOC>